Dr John Patterson joins board at Ferring
This article was originally published in Scrip
Ferring Pharmaceuticals (Switzerland) has appointed Dr John Patterson as a new board member. From December 2004 through to his retirement on March 31st, Mr Patterson was executive director at AstraZeneca. Before that, he held a number of roles in business and portfolio development for Zeneca and AstraZeneca and had an R&D career spanning 18 years with ICI Pharmaceuticals.